Overview
Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects
Status:
Withdrawn
Withdrawn
Trial end date:
2013-05-01
2013-05-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to evaluate the safety and efficacy of product 0405 in pediatric subjects with Mild to Moderate Atopic Dermatitis.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Fougera Pharmaceuticals Inc.
Criteria
Inclusion Criteria:- Clinical diagnosis of Atopic Dermatitis
- Good health with the exception of Atopic Dermatitis
- Percent body surface area minimum requirements
Exclusion Criteria:
- Subjects who are pregnant, nursing or planning a pregnancy